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Aminoacyl-tRNA synthetases (aaRSs) catalyze bonds between tRNAs and cognate amino 
acids. The formation of cognate aminoacyl-tRNAs is critical for cell viability, as translating 
noncognate aa-tRNAs leads to amino acid misincorporation and alterations in protein structure 
and function. While aaRSs make errors in most organisms, proofreading mechanisms also exist; 
however, our understanding of this machinery is poorly understood, particularly outside of 
prokaryotes. Unlike Escherichia coli (Ec), which possess a designated editing domain on prolyl-
tRNA synthetase (ProRS), some bacteria like Caulobacter crescentus (Cc), multicellular 
eukaryotes like humans (Homo sapiens, Hs), and plants like Arabidopsis thaliana (At), encode a 
separate editing enzyme called ProXp-ala that hydrolyzes non-cognate Ala-tRNAPro. Sequence 
alignments have revealed that the homologs in plants all possess a C-terminal extension absent in 
other species. This C-terminal domain (CTD) has a conserved sequence with no known structure 
or function to date. This work seeks to elucidate the structure and function of this highly conserved 
CTD of At ProXp-ala. Bioinformatics analyses and homology modeling studies revealed that the 
plant-specific CTD may be an oligomerization motif. Full-length wild type (WT) and truncated C-
terminal domain (∆CTD) At ProXp-ala and At tRNAPro have been expressed and purified from E. 
coli and their storage conditions were optimized. Homology models predicted that the CTD plays 
a role in protein oligomerization, which was supported by size-exclusion chromatography with 
multiple angle laser light scattering experiments. In vitro kinetic deacylation assays demonstrated 
a 19-fold decrease in activity without the CTD and a positive correlation between activity and 
enzyme concentration for the ∆CTD variant. These data suggest that the CTD plays a significant 
role in the activity of At ProXp-ala and are consistent with a model in which truncation results in 
impaired binding of the ∆CTD mutant to tRNAPro. Preliminary microscale thermophoresis binding 
assays were performed to test this hypothesis but require further optimization. Comparisons of 
plant and human ProXp-ala activity revealed similar deacylation rates between the human enzyme 
and ∆CTD At ProXp-ala. If the At CTD does indeed improve tRNA binding, then appending this 
domain to human ProXp-ala is expected to similarly improve its substrate binding activity and 
future work will address this hypothesis. The emphasis of this work on translational fidelity in 
plants is a novel direction in aaRS research that will significantly expand our understanding of 
eukaryotic editing mechanisms. Our comparative study of plant and human ProXp-ala has 
implications as to the potential limitations of human translational machinery and may inform future 
studies on the mechanisms of human disease related to sub-optimal translational fidelity. 
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Chapter 1: Introduction 
Translation is the process by which an organism’s genetic information in the form of 
mRNA is used to construct functional proteins from amino acids at ribosomes within cells. 
Transfer RNAs (tRNAs) are ubiquitously expressed non-coding RNAs that are responsible for 
delivering amino acids to ribosomes. tRNAs are substrates for aminoacyl-tRNA synthetases 
(aaRSs), which create chemical bonds between tRNAs and amino acids through a process called 
aminoacylation or “charging”1,2. Aberrations in aminoacylation and translational fidelity have 
detrimental effects on cells, including causing degradation and apoptosis in mammalian cells, as 
well as contributing to neurodegeneration3,4.  
The aminoacylation reaction occurs in two steps: activation and transfer (Fig. 1). In the 
first step, an aaRS will bind an amino acid and use ATP to form an activated aminoacyl adenylate 
(aa-AMP) precursor, releasing pyrophosphate (PPi). In the second step, the activated aa-AMP is 
transferred to either the 2' or 3' hydroxyl group (depending on the aaRS) at the 3' end of the bound 
tRNA (a region referred to as the “acceptor stem”), forming aminoacyl-tRNA (aa-tRNA)5,6. The 
aa-tRNA is then released from the aaRS active site and carried to the ribosome by elongation 







Figure 1. The aminoacylation reaction of aminoacyl-tRNA synthetases (E1) occurs in two steps: 
activation of the amino acid (AA) by ATP, then transfer of the aminoacyl adenylate (AA-AMP) to the 3’ 
acceptor stem of the tRNA. Dots separate bound species. 
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Most organisms possess at least twenty aaRSs, one for charging each of the common 
proteinogenic amino acids to all of its tRNA isoacceptors5.The primary products of aminoacylation 
reactions are cognate aa-tRNAs, which are tRNAs that are correctly charged with the amino acid 
encoded by their respective anticodon loops. For example, prolyl-tRNA synthetases (ProRSs) 
generate cognate Pro-tRNAPro aminoacyl-tRNAs that are made of a proline amino acid linked to a 
tRNA with a proline-encoding anticodon (AGG, CGG, GGG, UGG in most organisms). 
However, the process of aminoacylation is imperfect, and noncognate aa-tRNAs are often 
generated by aaRSs, which leads to mistranslation and the generation of mutant polypeptides, 
creating a necessity for translational proofreading machinery7. The large size of tRNAs provides 
ample elements for substrate discrimination, but the small sizes and similar structures of amino 
acids make amino acid selectivity a challenge for aaRSs8,9. Proteinogenic amino acids (and 
nonproteinogenic amino acids in appreciable concentrations) that are similar in molecular volume 
and composition to the cognate amino acid of a synthetase demonstrate the highest rates of 
mischarging (Fig. 2)9. Maintaining a steady intracellular pool of cognate aa-tRNAs is crucial for 
cells to be able to maintain fidelity during translation, since translation of mischarged aa-tRNAs 
introduces missense mutations into the nascent polypeptide, which has been found to result in  


















Selection for fidelity during translation is evident by the discovery of proofreading 
mechanisms that edit noncognate aa-tRNAs in all domains of life (Fig. 3)10. “Pre-transfer” editing 
occurs between the activation and transfer steps of aminoacylation (Fig. 3). For example, the Ec 
isoleucyl-tRNA synthetase (IleRS) recognizes a misactivated Val-AMP and hydrolyzes the bond 
before transfer of the amino acid to tRNA, successfully preventing mischarging11-13. However, it 
cannot always recognize Val-AMP at this step and may mischarge Val onto tRNAIle producing 
noncognate Val-tRNAIle. To prevent mistranslation, IleRS employs post-transfer editing in cis by 
having the acceptor stem of bound mischarged Val-tRNAIle interact with a separate editing domain 
on IleRS that will selectively remove Val from tRNAIle in a deacylation reaction (Fig. 3). This 
form of editing is called “post-transfer” editing. The latter can also be performed after aa-tRNA 
product release in trans, either by the synthetase itself, or by a free-standing trans-editing 
deacylase (Fig. 3)10,14. 
 
Figure 2. Amino acids frequently charged onto cognate tRNAs for selected synthetases. The cognate 
(black), proteinogenic (red) and nonproteinogenic (green) amino acids are shown. (Adapted from Jo 











The exact combination of proofreading mechanisms that is employed to ensure a high 
concentration of a specific cognate aa-tRNA (e.g., Pro-tRNAPro or Ile-tRNAIle) varies between 
aaRSs and organisms, as there is variability in the concentrations of noncognate amino acids in 
different cellular contexts. The exact sequences and domain architectures of aaRSs also vary 
among species, even within the same domain of life. For example, Ec ProRS charges all four 
tRNAPro isoacceptors with Pro in vivo, and while most noncognate amino acids, like His are not 
subject to aminoacylation due to the steric constraints of the ProRS active site (Fig. 4A), Ec ProRS 
has been found to successfully activate and mischarge noncognate Ala and Cys onto tRNAPro in 
vitro (Fig. 2)15,16. While Ec ProRS exhibits some degree of pre-transfer editing similar to that of 
Ec IleRS, this activity is not sufficient to prevent accumulation of Ala-tRNAPro, making post-
transfer editing necessary to fulfill the proofreading needs of Ec ProRS17. To clear Ala-tRNAPro, 
Ec ProRS contains an editing “insertion domain” (INS) that specifically deacylates mischarged 
Ala-tRNAPro, but not Cys-tRNAPro, though it is currently unclear whether the INS domain 
performs deacylation in cis or trans (Fig. 4A)14,18. To clear mischarged Cys-tRNAPro, Ec expresses 
Figure 3. Translational fidelity is ensured through various editing mechanisms: pre-transfer 
hydrolysis of aminoacyl-adenylate (AA-AMP), cis-post-transfer deacylation of noncognate 
aminoacyl-tRNA (AA-tRNA) by an aminoacyl-tRNA synthetase (E1) editing site, or trans-post-
transfer deacylation after product release by an aminoacyl-tRNA synthetase (E1) editing site or a 
free standing, trans-editing deacylase (E2). 
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YbaK, a structurally homologous, INS-like, free-standing trans-editing protein that forms a ternary 
complex with ProRS and Cys-tRNAPro, then subsequently deacylates Cys-tRNAPro (Fig. 4A)19-21. 
This “triple-sieve” mechanism of active site steric hinderance, INS domain editing, and YbaK 
trans-editing ensures that Pro-tRNAPro is the only aa-tRNAPro available for translation in Ec. 
A triple-sieve mechanism of Pro-tRNAPro proofreading is not employed by all species, and 
some bacteria even employ an alternative triple-sieve mechanism. For example, Caulobacter 
crescentus (Cc), exhibits Cys- and Ala-tRNAPro mischarging and expresses YbaK to clear Cys-
tRNAPro, but lacks an INS domain on ProRS to clear mischarged Ala-tRNAPro (Fig. 4B)22. Instead, 
Cc encodes a free-standing ProXp-ala domain that is structurally homologous to the Ec INS 
domain and performs Ala-tRNAPro editing in trans (Fig. 4B)23. Together, the two trans-editing 













(A)            (B) 
Figure 4. The “Triple Sieve” mechanism of (A) Ec ProRS employs steric effects (green), cis-post-
transfer editing by the INS domain (blue), and trans-post-transfer editing by Ybak (red) to ensure 
that Pro-tRNAPro is the only aa- tRNAPro available for translation. Instead of an INS domain, (B) Cc 
ProRS encodes the trans-editing protein ProXp-ala to deacylate Ala-tRNAPro. (Adapted from 
Vargas-Rodriguez & Musier-Forsyth, 2013; Das et al., 2014) 
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Most of our understanding of translational fidelity mechanisms, especially with regard to 
free-standing trans-editing proteins, has come from research in prokaryotic systems. Recent 
bioinformatics analyses have revealed a large superfamily of nine INS-like proteins, including 
YbaK and ProXp-ala, many of which are largely uncharacterized (Fig. 5A)14. Of these proteins, 
most are found almost exclusively in prokaryotes; however, ProXp-ala is found in a number of 
eukaryotes, and it is the only known INS superfamily member widely expressed in animals to date 
















Figure 5. (A) Sequence similarity network analysis of the INS Superfamily of trans-editing domains 
generated and performed by Marina Bakhtina. Each node represents a collection of similar 
sequences. Length of the lines  connecting nodes indicates degree of sequence similarity, revealing 
nine unique clusters of sequences. Six of these are consistent with established functional trans-
editing factors and three are new clusters currently called ProXp-7, ProXp-8, and ProXp-9. (B) 
Magnified image of the ProXp-ala cluster revealing sub-clustering within kingdoms. Nodes 
containing ProXp-ala species investigated in the Musier-Forsyth lab are identified with triangles. 
(A)       (B) 
 13 
While Cc ProXp-ala has been well characterized both structurally and functionally, 
eukaryotic trans-editing mechanisms, particularly in plants, are poorly understood. Clustal Omega 
sequence alignments of ProXp-ala from bacteria, plants, and animals (Fig. 6), reveal that plant 
ProXp-ala contains an extension on the C-terminus that is approximately 140 residues in length. 
BLAST searches revealed that this extension shares no detectable similarity to any known protein. 
Previous models of aaRS evolution include monofunctional proteins that have developed more 
complex, multi-domain architectures in response to selective evolutionary pressure over time24,25. 
Thus, the presence of a conserved C-terminal domain (CTD) on a plant protein whose N-terminal 
domain is closely related to other known ProXp-ala enzymes in bacteria and animals suggests that 
this CTD may contribute a novel function to plant ProXp-ala and account for its retention 
throughout plant evolution. ProXp-ala sequences with C-terminal extensions have been found in 
all plant phyla, indicating that the evolution of the CTD occurred before the divergence of plants 
from other eukaryotes. 
This thesis reports the insights gained in understanding the structure, function, and 
evolution of ProXp-ala in the model plant system Arabidopsis thaliana via bioinformatics and 
computational modeling (Chapter 2), and functional comparisons of full-length wild type (WT) 
and genetically truncated C-terminal domain (∆CTD) At ProXp-ala (Chapters 3 and 4). 
Translational fidelity in plants is a previously unexplored direction in aaRS research, thus this 





















Figure 6. Alignment of ProXp-ala sequences from bacterial (top, blue), plant (middle, green), and 
animal (bottom, red) species. The unique plant CTD is highlighted in yellow. 
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Chapter 2: Bioinformatics and Structural Predictions of Arabidopsis thaliana ProXp-ala 
Introduction 
While the structures of Ec Ybak (PDB ID: 2DXA) and Cc ProXp-ala (PDB ID: 5VXB), 
have been determined previously by X-ray crystallography, the structure of At ProXp-ala, 
including its unique C-terminal domain, is unknown. Initial alignments comparing Cc, Hs, and At 
ProXp-ala confirm the notable homology among approximately the first 165 N-terminal amino 
acids, after which Cc and Hs reach their C-terminus and At continues with a stretch of 
approximately 145 residues (Fig. 7). This pattern of homology suggested that the N-terminal 165 
amino acids of At ProXp-ala likely comprise a catalytic core that has preserved the Ala-tRNAPro 
editing activity as observed in Cc and Hs ProXp-ala. However, the addition of a conserved CTD 
in plants (Fig. 6) suggests that plant ProXp-ala may have evolved enhanced or novel functions that 
have been retained throughout evolution. This chapter will discuss some of the in silico techniques 
and software programs that have been employed to predict the secondary, tertiary, and potentially 
quaternary structures of At ProXp-ala, which informed the types of functions that were probed in 























Materials and Methods 
Porter 4.0, PaleAle 4.0 
 The amino acid sequence of At ProXp-ala was used as a query for the Porter 4.0, PaleAle 
4.0 protein structure prediction service. The Porter program outputs a secondary structure 
prediction for each residue (helix, strand, or coil) and the PaleAle program predicts the relative 
solvent accessibility (very buried, somewhat buried, somewhat exposed, very exposed) for each 
residue as well26. Together, these data can be used to predict the domain architecture and overall 
structure of a query polypeptide sequence. 
 
 
Figure 7. The At ProXp-ala sequence exhibits notable conservation with Cc and Hs ProXp-ala 
throughout the first 165 residues of the protein. Residues 166-308 (green) make up a C-terminal 
extension with no recorded structure or function. 
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SWISS-MODEL 
 The amino acid sequence of At ProXp-ala was used as a query for the SWISS-MODEL 
protein structure homology-modeling server. The query returned a number of INS-like domain 
proteins, including the Cc ProXp-ala crystal structure (5VXB), which was used to generate a 
homology model for At ProXp-ala, as well as Hs ProXp-ala which similarly lacks a known 
structure. SWISS-MODEL is only able to generate models that contain stretches with similar 
identity between the template and query sequence. Thus, the software was only able to generate a 
model using the N-terminal core of At ProXp-ala since there was not enough sequence identity to 
the CTD. To gain insights into the potential tertiary structure of the At ProXp-ala CTD, a new 
search was performed using only the C-terminal residues (164-308) of the protein. While 
homology models are not a sufficient substitute for actual structural data, probing the sequence of 
the CTD for homology to known structures provided insight into the possible functions that this 
extension could exhibit in vitro and in vivo, as discussed below. 
 
PyMOL Molecular Modeling Software 
 This program visualized the .pdb files generated by SWISS-MODEL. The homology 
models of Hs and At ProXp-ala were overlaid on top of the template structure of Cc ProXp-ala 
(5VXB) and very strong structural similarity was observed, as nearly all secondary structures 
overlapped perfectly among the three proteins. To confirm that structural similarities were not 
merely the result of the program forcing the query sequence to fit the template model, 5VXB was 
also used as a template for the CTD sequence of At ProXp-ala; these sequences have no notable 
homology to one another. The resulting structure lacked the significant secondary structure overlap 
seen in the other model and was almost entirely composed of random coils (data not shown). 
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Results and Discussion 
Predicted Domain Architecture of At ProXp-ala 
 The Porter,PaleAle program output revealed important structural predictions for the C-
terminal extension of At ProXp-ala (Fig. 8). The N-terminal catalytic core of the protein exhibits 
a mixture of secondary structures and random coils, with significant variation in solvent 
accessibility. These observations are consistent with the results expected for a soluble, globular 
single-domain protein, and are also consistent with the results found when using Cc or Hs ProXp-
ala as query sequences (data not shown). However, the C-terminal extension appears to lack this 
globular structural signature, and instead is predicted to contain a disordered, highly exposed 
random coil that is followed by a long a-helical domain. These findings suggest that the C-terminal 
extension contains a potentially functional, long a-helical nucleic acid or protein interaction 
domain that is connected to the N-terminal catalytic core via a long, random coil linker region 
 
Homology-Based Functional Predictions of At ProXp-ala Domains 
The SWISS-MODEL program and PyMOL imaging software were used to generate and 
visualize homology models of Hs ProXp-ala and the N-terminal core of At ProXp-ala. Their 
structures can be seen overlaying the Cc ProXp-ala template structure (5VXB) from which they 
were generated (Fig. 9). There is clear overlap between all three structures and given the similar 
primary sequence and secondary structure predictions of the three proteins, this predicted structural 
conservation at the tertiary level is consistent with the hypothesis that At ProXp-ala retains the 


























0° 90° 180° 270° 
Figure 9. Homology models of At (green) and Hs (orange) ProXp-ala generated by SWISS-MODEL 
overlaying the Cc (blue) ProXp-ala template structure 5VXB. Each image is an approximate 90 degree 





















Figure 8. Porter,PaleAle structural predictions of At ProXp-ala. 1: At ProXp-ala 
sequence. 2: Porter secondary structure prediction, H=helix (red), E=b-strand (green), 
C=coil (uncolored). 3: PaleAle relative solvent accessibility prediction, B=very buried 
(yellow), b=somewhat buried (uncolored), e=somewhat exposed (uncolored), E=very 
exposed (blue). * marks the apparent separation between the N-terminal catalytic core 
and the C-terminal extension.   
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Since the initial homology model in Fig. 9 could not be generated for the CTD, the 
sequence of C-terminal residues was used as a SWISS-MODEL query to probe for homologous 
sequences and structures for just the CTD. Initial searches returned a template structure with 
21.05% sequence identity to latter half of the CTD including a highly helical region predicted 
previously in Fig. 8. This protein, Chlamydia trachomatis (Ct) plasmid gene product 3 (Pgp3), is 
a large, three-domain protein that was crystallized as a homotrimer. An individual image of the 
CTD homology model can be seen in Fig. 10B, and an overlay of the At ProXp-ala CTD on the Ct 
















Figure 10. Homology modeling of the At ProXp-ala CTD by SWISS-MODEL using the Ct Pgp3 crystal 
structure template. (A) Sequence alignment of the region with 21% identity between the At ProXp-
ala CTD (Model_01) and Ct Pgp3 (4jdm.1.A). (B) Predicted structure of helical region of At ProXp-
ala CTD. (C)  Overlay of At ProXp-ala CTD homology model (green) on one of three identical chains 











Based on the aforementioned secondary and tertiary structural predictions, the CTD of At 
ProXp-ala is hypothesized to contain a long linker region that connects the N-terminal catalytic 
deacylase core to an a-helical domain. The homology of the coiled region to a Ct Pgp3 homo-
trimerization domain suggests that this helix may facilitate protein-protein interactions, possibly 
even homo-oligomerization, that may be critical for performing both its canonical Ala-tRNAPro 
editing function, as well as any novel noncanonical functions in vivo. Proteolysis experiments to 
investigate this predicted domain architecture model are planned for the near future. 
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Chapter 3: Purification of Arabidopsis thaliana ProXp-ala and tRNAPro 
Introduction 
The results of the bioinformatics and modeling studies described in Chapter 2 have 
suggested that At ProXp-ala is very likely to possess Ala-tRNAPro deacylation activity catalyzed 
by its N-terminal catalytic core, while homology modeling of the C-terminal extension suggests 
that it may be a protein-protein interaction domain. To probe these hypothesized functions and any 
other potential functions of the C-terminal extension of At ProXp-ala, the relevant macromolecules 
needed to be purified.  
Full-length (wild-type, WT) At ProXp-ala and a truncated variant containing a C-terminal 
domain deletion (∆CTD) were prepared. WT At ProXp-ala is a 35-kDa protein that is 308 residues 
in length, averaging around 180% of the size of ProXp-ala found in Cc and Hs, which are 168 and 
172 residues long, respectively (Fig. 7). To generate an effective ∆CTD mutant, all of the critically 
conserved residues necessary for enzymatic function in ProXp-ala expressed in other species were 
retained in the mutant. The truncation was designed and constructed by Jun-Kyu Byun. ∆CTD is 
a 20-kDa protein lacking residues 166-307, which are predicted to form a disordered random coil 
linker and a long a-helical domain (Fig. 8). Both constructs were designed with N-terminal His6 
tags with sizes of approximately 2-kDa, resulting in molecular weights of 37-kDa and 22-kDa for 
WT and ∆CTD, respectively. 
In addition to purifying the WT and mutant proteins, an appropriate At tRNAPro substrate 
was necessary for the functional assays. Like most eukaryotes, At encodes a number of tRNAPro 
isoacceptors, each of which  is 76 nucleotides in length with a CCA-3' acceptor stem and one of 
the four proline anticodons at nucleotide positions 34-36: UGG, GGG, AGG, or CGG. For this 
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study, the sequence of the UGG anticodon was chosen because 70% of the tRNAPro encoding 
genes in At use this anticodon according to the Genomic tRNA Database (gtRNAdb). 
 
Materials and Methods 
Electrocompetent E. coli Transformation with Plasmids 
 To purify WT At ProXp-ala, the DNA sequence of Kyoto Encyclopedia of Genes and 
Genomes (KEGG) entry AT1G44835 with an N-terminal His-tag was purchased by Lin Chen and 
cloned by her into a pET15b vector, which contains an upstream inducible lac operon and an 
ampicillin resistance (ampR) cassette. Electrocompetent BL21(DE3)RIL E. coli (chloramphenicol 
resistant, camR) were transformed with this plasmid via electroporation and grown overnight at 
37°C after plating on solid LB media with ampicillin (amp) and chloramphenicol (cam). A single 
colony was used to inoculate a 35 mL starter culture of liquid LB+amp+cam media overnight. The 
next day, the starter culture was added to 1 L of LB+amp+cam liquid media, and once the culture 
was grown to an OD600 of 0.6, a 1 mL aliquot was withdrawn and used to prepare a WT At ProXp-
ala pET15b BL21(DE3)RIL glycerol stock (ampR, camR), which was stored at -80°C. The 
remaining culture was used for protein purification as outlined below. 
A CTD deleted At ProXp-ala (∆CTD) construct was generated by Jun-Kyu Byun via site-
directed, ligase-independent mutagenesis (SLIM)27. BL21(DE3)RIL E. coli were transformed with 
this plasmid and used to prepare a ∆CTD glycerol stock as described for the WT sequence.  
The desired tRNA construct containing the At tRNAPro(UGG) sequence with an upstream T7 
promoter flanked by BstNI endonuclease restriction enzyme recognition sites was designed and 
purchased by Lin Chen and cloned by her into a pUC57 vector (ampR). This plasmid was 
transformed into electrocompetent XL1-Blue E. coli via electroporation and grown on solid 
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LB+amp media. A single colony was selected and used to inoculate a 100 mL LB+amp liquid 
media culture and grown to an OD600 of 0.6. A 1 mL aliquot was withdrawn and used to prepare a 
WT At tRNAPro(UGG) pUC57 XL1-Blue glycerol stock, which was stored at -80ºC. 
 
Protein Purification 
 To purify WT and ∆CTD At ProXp-ala, the appropriate  pET15b BL21(DE3)RIL glycerol 
stock was streaked onto LB+amp+cam plates. A single colony for each construct was selected and 
grown in a 35 mL starter culture of liquid LB+amp+cam media at 37°C overnight. The next day, 
the starter culture was used to inoculate a 1 L culture of liquid LB+amp+cam media and allowed 
to grow for 2-3 h until the OD600 reached 0.6. At this point, the culture was placed on ice for 20 
min to induce expression of cold-shock chaperone proteins which enhance protein solubility. 
Isopropyl β-D-1-thiogalactopyranoside (IPTG), an allolactose molecular mimic, was added to the 
media (100  µM final concentration), triggering the upstream lac operon to induce transcription of 
the WT or ∆CTD At ProXp-ala gene. Induction was performed overnight at 25°C and was 
confirmed via denaturing sodium dodecyl sulfate 12% (w/v) polyacrylamide gel electrophoresis 
(SDS-PAGE) (Fig. 11A).  
 The induced cultures were grown overnight, and the cells were harvested the next day by 
centrifugation (6,000 relative centrifugal force (rcf), 15 min, 4°C). The total cell pellet mass was 
determined, and one cOmplete, Mini Protease Inhibitor Cocktail tablet (Roche) was added for each 
gram of cell pellet. The cells and tablets were mixed in 10 mL/gram of pellet of lysis buffer (50 
mM NaPi pH 7.5, 600 mM NaCl, 20 mM b-mercaptoethanol (b-ME, a reducing agent), 10% v/v 
glycerol) with 100 mg/gram of pellet of lysozyme from chicken egg white (Sigma-Aldrich). Once 
the cells were fully resuspended and the tablets were dissolved, the solution was incubated on ice 
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for 30 min. Following incubation, the cells were lysed further via sonication on ice (9 rounds of 
40 s of 1 s on/off pulses followed by 40 s of rest). The lysed cell fragments were centrifuged 
(27,000 rcf, 30 min, 4°C), and the supernatant was removed with a syringe and filtered through 
0.45 µm syringe filters. 
 Ni-NTA affinity columns were prepared at 4°C by packing 5 mL HIS-Select Ni-NTA Resin 
(Sigma-Aldrich) between the frits of 5 mL disposable polypropylene columns (QIAGEN). The 
columns were washed with 50 mL of pure water and equilibrated with 20 mL of the 
aforementioned lysis buffer. The filtered lysates for each protein were loaded onto separate 
columns, and the flow-throughs were collected. A 9-step gradient from 0 to 250 mM (0, 5, 10, 20, 
30, 40, 60, 80, and 250 mM) imidazole, a His-side chain mimic, was used to elute the proteins and 
the fractions were collected separately before being run on a 12% SDS-PAGE gel to locate the 
fractions with the purest protein (Fig. 11B-C).  
 If the elution fractions were of sufficient purity, Amicon Ultra-15 Centrifugal Filter units 
(WT: 30,000 MWCO; ∆CTD: 10,000 MWCO) were used to concentrate the desired fractions by 
centrifugation (4,000 rcf, 10 min, 4°C). After the sample volume was reduced to below 1500 µL, 
the filter unit was filled with the appropriate protein storage buffer (WT: 500 mM NaPi pH 6.0, 
500 mM NaCl, 1 mM DTT; ∆CTD: 500 mM NaPi pH 7.5, 150 mM NaCl, 1 mM DTT) and 
centrifugation was repeated three times to ensure sufficient buffer exchange. After the third round 
of exchange, the sample volume was reduced to 600 µL and combined in a 1:1 ratio with 80% 




























Figure 11. SDS-PAGE gels showing protein induction and purification results. Gels contained 12% polyacrylamide and 
were electrophoresed at 200 V for 45 min. (A) Induction test: 1 mL aliquots were drawn from each cell culture before 
(Pre) and after (Post) addition of IPTG. Each aliquot was centrifuged (17,000 rcf, 5 min, 4 °C) and the resulting pellet 
was resuspended in a 1:1 ratio of 2X protein loading buffer. Previously purified WT protein is used as an additional 
reference marker. Ni-NTA affinity column purification showing eluted fractions for WT (B) and ∆CTD (C) At ProXp-ala. 
Lanes contain 10 µL of the collected eluant after sequential loading of 20 mL (0-5 mM), 10 mL (10 mM), or 5 mL (20-250 
mM) of lysis buffer with the indicated concentration of imidazole. WT is used as an additional reference marker in (C). 
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 If high and low molecular weight impurities were present after the elution step,  purification 
was continued with size-exclusion chromatography (SEC).  The desired fractions were combined 
in Amicon Ultra-15 Centrifugal Filter units (WT: 30,000 MWCO; ∆CTD: 10,000 MWCO) and 
centrifuged (4,000 rcf, 10 mins, 4°C) to concentrate the sample to less than 1 mL. The sample was 
then injected onto a Superdex 75 10/300 gel filtration column (Cytiva) equilibrated with the 
appropriate protein storage buffer (see above) using a Bio-Rad fast protein liquid chromatography 
(FPLC) instrument. After sample injection,  240 mL (two column volumes) of the desired storage 
buffer was pumped through the column by the instrument at a rate of 0.25 mL/min. Fractions (2 
mL) were collected throughout loading and elution, and a UV laser was used to detect the presence 
of protein in each fraction. The resulting UV chromatogram was used to identify fractions 
containing protein. Aliquots from these fractions were electrophoresed on 12% SDS-PAGE gels, 
and fractions containing the desired protein were combined, concentrated, and buffer exchanged 
into protein storage buffer in Amicon Ultra-15 Centrifugal Filter units, as described previously. 
Proteins were combined 1:1 with 80% (v/v) glycerol and stored at -20°C. 
 
T7 RNA Polymerase in vitro tRNA Transcription and Gel Purification 
 The previously described At tRNAPro(UGG) pUC57 XL1-Blue glycerol stock was streaked 
onto LB+amp plates. A single colony was selected and used to inoculate a 35 mL starter culture 
of liquid LB+amp media overnight. The next day, the starter culture was added to a 1 L culture of 
liquid LB+amp media and grown at 37°C for 2-3 h until OD600 was between 0.4 and 0.6. The cells 
were then harvested by centrifugation, and the DNA was extracted following the QIAGEN Maxi 
Prep protocol. The concentration of collected DNA was measured using UV-Vis spectroscopy on 
a NanoDropOne instrument. 
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 To generate a stable template for transcription, 100 µg of plasmid DNA was digested with 
15 µL of 1U per 1 µg/µL BstNI endonuclease in 200 µL 1X NEB Buffer 3.1. A 5 µL sample of 
the digestion reaction was electrophoresed on a 1% (w/v) agarose gel containing ethidium bromide 
at 100 V for 60 min before it was imaged with UV light to confirm the presence of the desired 215 
base pair band determined by plasmid mapping (Fig. 12A).  A 1 mL in vitro transcription of the 
100 µg of BstNI digested DNA product using 50 µL of homemade T7 RNA polymerase (volume 
determined based on assay of enzyme efficiency) was performed at 37°C for 3.5 h in 1X NEB T7 
transcription buffer, 4 mM NTPs, 20 mM MgCl2, 5 mM DTT, and 5 µM PPi-ase28. The 
transcription product was then electrophoresed on a denaturing 12% (w/v) polyacrylamide/7 M 
urea gel at 450 V for 3 h. The gel was imaged under a UV light and the tRNA band was excised 
from the gel, crushed, and soaked in 15 mL of RNA extraction buffer (500 mM NH4OAc, 1 mM 
EDTA, pH 8.0) overnight with vigorous shaking at 37°C (Fig. 12B). After extraction, the 
tRNAPro(UGG) solution was centrifuged (3000 rcf, 5 min, 4°C) and the supernatant was filtered 
through 0.45 µm filters to prevent gel pieces from continuing through the purification.  
 The filtered tRNA was concentrated to a volume of 400 µL via butanol extraction and then 
precipitated via overnight storage at -80°C in 800 µL of cold 100% ethanol and 40 µL of 3 M 
sodium acetate (pH 5.0). The next day, the samples were centrifuged (13,300 rcf, 45 min, 4°C) 
and the ethanol buffer was decanted leaving behind a white tRNA pellet. The pellet was washed 
in 300 µL of 70% (v/v) ethanol, centrifuged (13,300 rcf, 20 min, 4°C), decanted again, and finally 
left to air dry for an hour. The dried pellet was then resuspended in sterilized, filtered, MilliQ 
water, and stored at -20°C. The concentration of the tRNA stock was determined by NanoDropOne 
















Bradford Assay for Protein Concentration 
 Since the sequence of At ProXp-ala lacks tryptophan (Trp) residues necessary for 
determining protein concentration using A280, the Bradford assay was used to determine the 
concentration of the purified WT and ∆CTD At ProXp-ala protein stocks29. In the presence of 
protein, Bio-Rad Bradford Dye changes from a reddish-brown color to a blue species that absorbs 
at 550 nm. This assay employs a known standardized protein solution to proportionately determine 
the concentration of the protein of interest. Bovine serum albumin (BSA) that was dissolved from 
powder to 10 mg/mL and diluted 10-fold to 1 mg/mL (verified using e280 of 0.67 L Da-1 cm-1 for 
BSA) was used as the standard. 
Figure 12. At tRNAPro purification gels showing successful plasmid digestion and in vitro transcription. (A) 
QIAGEN Maxi-Prep purified DNA analyzed by 1% (w/v) agarose gel electrophoresis (100 V for 60 min) before 
and after addition of BstNI endonuclease. The desired tRNAPro gene with a T7 promoter is expected to migrate 
as a 215 bp fragment. (B) T7 RNA polymerase-mediated in vitro transcription product analyzed by 12% (w/v) 
polyacrylamide/7 M urea gel electrophoresis (450 V for 3 h). Previously purified At tRNAPro was run on the left 
side as a control. Only the largely enriched band was excised for subsequent purification. 
 
















-Expected 215 bp At tRNAPro gene band 
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 Standard protein solutions (800 µL) were prepared using 0 to 14 µL of 1 mg/mL BSA 
titrated in 2 µL increments.  Bio-Rad Bradford Assay Dye (200 µL) was added to each solution-
containing cuvette and the A550 was measured via NanoDropOne after 15 min. The A550 of each 
sample was plotted against the volume of BSA added and the fitted linear change in A550 was used 
to calibrate the slope of the BSA line.  
 Using the proteins of interest (WT and ˙DCTD At ProXp-ala), 800 µL protein solutions 
were similarly prepared, ranging from 2-10 µL of protein stock solution in 2 µL increments. The 
A550 was measured 15 min after the addition of 200 µL Bio-Rad Bradford Assay Dye, and the 
measured A550 readings were plotted against solution protein volume and fit to a line. Using the 
ratio of the slope of the normalized BSA line and the known ~1 mg/mL BSA concentration as a 
proportionality factor, the fitted slope of the line for the proteins of interest could be used to 
determine the concentration of target protein. 
 
Buffer Stability Assay 
It was observed via SDS-PAGE that months after storage in the original protein storage 
buffer used for previously studied ProXp-ala species like Cc and Hs (500 mM NaPi pH 7.5, 150 
mM NaCl, 1 mM DTT), WT ProXp-ala stocks would exhibit increasingly larger fractions of the 
total protein in high MW bands relative to the monomeric 37-kDa band that predominates after 
purification (data not shown). This observation suggested that these buffer conditions were 
promoting formation of high MW oligomers or aggregates that may influence functional protein 
activity. To optimize the storage conditions of the WT protein, 50 µL of highly pure protein (~100 
µM) were buffer exchanged in triplicate into 18 different NaPi buffers of different pH (6.0, 7.0, 
8.0), salinity (NaCl: 0 mM, 250 mM, 500 mM), and reducing environment (DTT: 0 mM, 5 mM). 
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A single replicate of each condition was stored in 40% (v/v) glycerol at -80°C, -20°C or 4°C. The 
buffer that retained the greatest monomer to oligomer ratio upon visual inspection was ultimately 
selected for improved long-term storage of this protein. 
 
Circular Dichroism Spectroscopy 
 Since the CTD is predicted to be highly a-helical, truncation of this domain would be 
expected to produce a large reduction in the amount of a-helix relative to WT. To measure the 
difference in secondary structure composition between WT and ∆CTD At ProXp-ala, Jun-Kyu 
Byun performed circular dichroism (CD) spectroscopy, which measures changes in molar 
ellipticity (q) at various wavelengths. A strong dip in molar ellipticity at 208 and 220 nm 
corresponds to the characteristic signal of a-helices. Significant differences in the sizes of these 
peaks indicate differences in the a-helix composition of the proteins of interest. 
 
Size Exclusion Chromatography 
 The homology of the CTD of At ProXp-ala to a trimerization domain of Ct Pgp3 suggested 
that the CTD may function as an oligomerization domain. To determine the oligomeric states 
sampled by WT and ∆CTD At ProXp-ala, purified WT or ∆CTD was loaded by Dr. William 
Cantara onto a size exclusion chromatography column that flowed through a multi-angle laser light 
scattering detector. This instrument then used UV absorbance at 280 nm and the retention volume 
of the sample to generate a spectrum. The column was calibrated so that the retention volume of a 




Results and Discussion 
Protein and tRNA Purification Yields and Purity  
Induction of both WT and ∆CTD At ProXp-ala was consistently successful, and both 
proteins remained primarily in the soluble fraction during the purification process as shown in the 
representative gel in Fig. 11A. Both proteins eluted from the Ni-NTA affinity column, although 
there were often high molecular weight contaminants observed during WT purification. Passing 
this protein through a SEC column did not significantly improve purity and the intensity of the 
high molecular weight bands increased consistently over time (data not shown).  
These results suggested that WT At ProXp-ala is a highly soluble protein that may form a 
single dominant oligomeric state in solution but oligomerizes over time. We hypothesized that the 
high molecular weight bands may be tightly interacting oligomers that are not dissociated even 
with denaturing conditions (SDS-PAGE and boiling water bath for 10 min). Further support for 
this hypothesis comes from the fact that the lowest high-molecular weight band exhibits a 
molecular weight that would be consistent with a dimer (~80 kDa), suggesting that these bands are 
likely due to irreversible higher order structures and not random protein aggregation (Fig. 13).  
After gel purification, approximately 200 µg of tRNA was recovered for each 1 mL T7 
RNA polymerase transcription reaction from 100 µg of original DNA template. The tRNA ran 
consistently on the urea-PAGE gels and could be excised for extraction from the gel (Fig. 12B). 
 
ProXp-ala Buffer Storage Optimization 
When comparing buffer storage conditions after two weeks, the samples stored at -20°C 
were indistinguishable from one another, confirming prior observations that this potential 
oligomerization occurs over long periods of time during -20°C storage. However, marked 
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differences were observed between the protein stocks stored at 4°C (Fig. 13A-B). pH had the 
greatest effect on stability, as all of the stocks stored at pH 6.0 (Fig. 13A, lanes 2-4) showed less 
high MW banding than those at pH 7.0 (Fig. 13A, lanes 5-7), which showed less than those stored 
at pH 8.0 (Fig. 13A, lanes 8-10). Additionally, salinity also had an effect on stability; for each pH 
tested, those stored in high salt conditions (Fig. 13A, lanes 2/5/8) resulted in fewer high MW bands 
compared to those stored with less salt (Fig. 13A, lanes 3/6/9) or no salt (Fig. 13A, lanes 4/7/10).  
Lastly, by comparing the lanes in Fig. 13A to those in Fig 13B, which only differ by the presence 
or absence of 5 mM DTT, respectively, the reducing environment also appeared to have a slight 
effect at reducing the formation of high MW bands (i.e. Fig. 13A, lane 5 and Fig. 13B, lane 4).  
The best storage conditions found for the WT protein were low pH, high salt, and high 
DTT (Fig. 13A, lane 2). Following these results, the WT protein was henceforth stored in 500 mM 
NaPi pH 6.0, 500 mM NaCl, 1 mM DTT and 40% glycerol. Notably fewer high MW species have 
been observed over time since this buffer was adopted. While this optimization assay was not 
performed for the ∆CTD based on its stability in the previously established buffer conditions, the 
fact that the ∆CTD protein does not exhibit the same level of aggregation implies that the CTD 
likely has a role in this activity and could potentially be serving as a homo-oligomerization 































Figure 13. 12% SDS-PAGE gels showing WT At ProXp-ala stocks stored at 4°C for 14 days in different 
pH and salinity buffer conditions and a highly (A) or poorly (B) reducing environment. All nine conditions 
are listed in the same order from left to right on each gel.  
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Impact of At ProXp-ala Truncation on Structure and Oligomerization 
   Once purification was completed and the concentration of each protein stock determined 
via Bradford assay, Jun-Kyu Byun performed CD spectroscopy to assess any changes in overall 
secondary structure that occurred upon truncation. The previously mentioned, computational tools 
(see Chapter 2) predicted that the CTD of At ProXp-ala was primarily a-helical. The decrease in 
molar ellipticity signal intensity at 208 and 220 nm observed by CD supports this prediction (Fig. 
14A). The general similarity between the two curves suggests that the secondary structures within 
the N-terminal domain were not severely impacted upon truncation (Fig. 14A). 
 Using purified WT and ∆CTD At ProXp-ala, Dr. William Cantara performed duplicate 
SEC-MALLS experiments to probe the different homo-oligomeric states that each protein formed 
in solution (Fig. 14B). The spectra indicate that WT At ProXp-ala adopts several oligomeric states, 
ranging from a dimer to a hexamer, with a dominant trimer and almost no monomer. In contrast, 
the spectrum for the ∆CTD indicates no oligomerization activity, as ∆CTD elutes exclusively as a 
monomer, suggesting that the CTD does indeed possess the same oligomerization capability as the 
helical region of the Ct Pgp3 antigen. However, a single strong trimeric peak was not observed, as 
would have been expected from clear homo-trimerization activity, so it is currently unclear which 
of these oligomeric states may be the most relevant in vivo. Once more is known about the 
interacting partners of WT ProXp-ala in vivo, more experiments will be performed to probe the 































Figure 14. CD and SEC-MALLS spectra comparing WT and ∆CTD At ProXp-ala. (A) CD spectra of 
WT (red) and ∆CTD (blue) At ProXp-ala. a-helices give high signal intensity at 208 and 220 nm. (B) 
SEC-MALLS spectrum of WT (red) and ∆CTD (blue) At ProXp-ala indicating oligomeric states 
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Chapter 4: Characterization of Arabidopsis thaliana Deacylation Kinetics in vitro 
Introduction 
 The established in vitro function of ProXp-ala in prokaryotes and humans is deacylation 
of mischarged Ala-tRNAPro. Briefly, ProRSs present in all domains of life mischarge Ala onto 
cognate tRNAPro. In some bacteria, like Ec, an editing domain is encoded within the synthetase, 
but other bacteria, including Cc, encode a separate trans-editing protein known as ProXp-ala. It 
is known that Cc ProXp-ala functions as a trans-editing deacylase along with Cc YbaK to clear 
Ala-tRNAPro and Cys-tRNAPro, respectively14,23. However, YbaK sequences are not found in 
eukaryotes, which raises questions as to how eukaryotic systems manage the challenges of 
translational fidelity. It has been found that Hs ProXp-ala deacylates Hs Ala-tRNAPro much more 
slowly that Cc ProXp-ala deacylates Cc tRNAPro, suggesting that there may have been less 
selective pressure for robust translational fidelity in humans than in bacteria. Alternatively, other 
factors present in vivo that are missing in our in vitro system may facilitate human ProXp-ala 
deacylation. The difference between prokaryotic and eukaryotic mechanisms has sparked greater 
interest in studying translational fidelity in other kingdoms like plants, fungi, and protists. 
Sequence alignments of ProXp-ala revealed that a CTD exclusive to plants could give 
some insight into eukaryotic translational fidelity, and comparisons of the deacylation ability of 
At ProXp-ala to that of Cc and Hs are of particular interest as it is not known to what degree the 
CTD may participate and influence this process. Since ProXp-ala has never been studied in 
plants to date, our first functional experiments were to confirm that At ProXp-ala exhibits the 
same canonical function as other ProXp-ala enzymes, then probe how the unique plant-specific 
CTD impacts that function. 
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Single-turnover kinetic deacylation assays revealed robust At Ala-tRNAPro deacylation by 
the WT enzyme and a significant defect in deacylation activity upon truncation of the CTD. Our 
results are consistent with a binding defect and prompted further study to quantify the difference 
in affinity via microscale thermophoresis (MST). MST measures the strength of the interaction 
between two binding partners, one of which is fluorescently labeled, by monitoring the change in 
fluorescence that occurs when the labeled molecule moves through a temperature gradient induced 
by an IR laser. Temperature changes and binding interactions change the energetic environment 
of the fluorophore, resulting in a change in signal. Additionally, the solvation entropy of the bound 
complex is different from the free protein, resulting in a difference in the rate at which the two 
species move when trying to reach equilibrium within the applied thermal gradient. All of these 
effects manifest as an MST signal that can be measured by comparing the fluorescence before and 
after the application of the thermal gradient. If binding events are observed, plotting the change in 
fluorescence against substrate concentration on a log scale should generate a sigmoidal curve that 
can be used to calculate the strength of the interaction via the dissociation constant, Kd. 
 Another set of deacylation experiments was performed using human tRNAPro and human 
ProXp-ala (purified using appropriate sequences in the same vectors and cell lines used for the At 
constructs) to make preliminary comparisons regarding the degree of functional conservation of 
ProXp-ala deacylation activity among eukaryotes. These results led to new hypotheses regarding 






Materials and Methods 
3'-[32P] Radiolabeling of tRNAPro 
A 100 µL reaction containing 1 µM purified At tRNAPro mixed with 2.7 µM purified 
nucleotidyltransferase (NTase) and 25 µL radioactive a-32P-ATP (Perkin Elmer, ~0.50 mCi, 25 
µL) in labeling buffer (50 mM glycine pH 9.0, 10 mM MgCl2, 50 µM NaPPi) was incubated at 
37°C. After 5 min, the last two components of the 100 µL reaction were added (10 µM 
pyrophosphatase (PPiase) and 1 µM CTP) and the reaction was incubated at 37°C for 2 min. This 
protocol selectively exchanges the 3' adenosine of At tRNAPro with a radioactively labeled 
adenosine, generating radiolabeled 3'-[32P]-tRNAPro30.  
 To separate the NTase from the tRNA after the reaction , 100 µL acid-phenol:chlorophorm 
(Ambion) was vortexed with the solution, then spun in a benchtop microcentrifuge (13,300 rcf, 1 
min, 4°C). The phenol layer was then removed, and this process was repeated. To remove the 
excess free a-32P-ATP, Quick Spin Sephadex G-25 Columns were prepared by two rounds of 
centrifugation (1,900 rcf, 1 minute, 4°C). The top, aqueous layer of the acid-phenol:chloroform 
extraction was loaded onto the column and the ~75 µL radioactive flow-through was collected.  
 The tRNA was precipitated via overnight storage at -80°C in 200 µL of cold 100% ethanol 
and 10 µL of 3 M sodium acetate (pH 5.2). The next day, the sample was centrifuged (13,300 rcf, 
30 mins, 4°C) and the ethanol buffer was decanted into a hot sink, leaving behind a white tRNA 
pellet that was washed in 300 µL of 70% (v/v) ethanol, centrifuged (13,300 rcf, 10 mins, 4°C), 
decanted again, and finally left to air dry for an hour. The dried pellet was then resuspended in 10 
µL of sterilized, filtered, MilliQ water, and stored at -80°C. 
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At tRNAPro Mischarging with Alanine using A. thaliana ProRS 
 Since At ProRS naturally mischarges tRNAPro with Ala when there is no competition with 
cognate Pro, and it lacks a cis- or trans-editing domain to deacylate this substrate, At ProRS is an 
optimal way to effectively generate substantial quantities of mischarged At Ala-tRNAPro. To 
generate Ala-tRNAPro substrate, 50 µM cold tRNAPro was mixed with 10 µL of radiolabeled tRNA 
(concentration of the radiolabeled tRNA < 2 µM, so the radioactivity levels of the sample were 
considered to represent 50 µM tRNA). The tRNAs were then refolded with a 2 min incubation at 
80°C, followed by a 2 min incubation at 60°C, the addition of MgCl2 (10 mM final concentration), 
and finally a 5 min incubation at 25°C.  
 The 200 µL mischarging reaction was performed in the following conditions: 10 µM At 
ProRS (purified by Lin Chen), 5 µM 3'-[32P]-radiolabeled At tRNAPro mix, and 1 M Ala, incubated 
for 10 min at  37°C in mischarging buffer (50 mM HEPES pH 7.5, 20 mM KCl, 20 mM b-ME, 10 
mM MgCl2, 4 mM ATP, 100 µM BSA, 6.25% v/v PPiase). The reaction was quenched with an 
equal volume acid-phenol:chloroform before it was vortexed and centrifuged (13,300 rcf, 1 min, 
4°C) to separate the aqueous and phenol layers. The phenol layer was then discarded, and the 
extraction was repeated. After the second separation, the mischarged tRNA in the aqueous layer 
was collected and precipitated in 400 µL of cold 100% ethanol and 20 µL of 3 M sodium acetate 
(pH 5.2) overnight at -80°C. The next day, the samples were centrifuged (13,300 rcf, 45 mins, 
4°C) and the ethanol buffer was removed. The resulting pellet was washed in 400 µL of 70% (v/v) 
ethanol, centrifuged (13,300 rcf, 20 mins, 4°C), decanted again, and finally left to air dry for an 
hour. The dried pellet was resuspended in 3 mM sodium acetate (pH 5.2) and stored at -80°C. 
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To determine the concentration of Ala-tRNAPro and the degree of aminoacylation, an S1 
nuclease (ThermoFisher) digestion was performed to cleave off the 3'-[32P]-AMP of the tRNA. A 
total of 70 µL of S1 nuclease quenching solution (1600 U S1 nuclease, 1.3 mM S1 nuclease buffer, 
130 mM sodium acetate pH 5.2) was prepared using ThermoFisher reagents. 6 µL of S1 quenching 
solution was combined in duplicate with 2 µL of tRNAPro before or after the aminoacylation 
reaction, and the solutions were left to incubate at room temperature for 30 min. 
To separate mischarged Ala-[32P]-AMP from uncharged free 3'-[32P]-AMP, the reactions 
were spotted in triplicate on polyethyleneimine-cellulose thin layer chromatography (TLC) plates 
(MilliporeSigma). Once the spots dried, the plates were placed in TLC chambers and separated 
with a mobile phase of ammonium acetate TLC plate running buffer (100 mM ammonium acetate, 
5% v/v acetic acid) until the solvent front was 1 cm from the top of the plate. The plate was 
removed from the chamber and allowed to air dry before being wrapped in clear film and placed 
in a photosensitive cassette overnight. The next day, the radioactive TLC plate was removed, and 
the exposed cassette was imaged with a Typhoon phosphorimager. Ala-[32P]-AMP migrates 
farther up the plate than uncharged free 3'-[32P]-AMP, so ImageQuant densitometry software was 
used to measure the pixel density of each radioactive spot on the TLC plate image. The degree of 
charging was determined by taking the pixilation volume of the higher Ala-[32P]-AMP spot over 
the sum of both the charged and uncharged spots. The concentration was determined by 






Single-Turnover Deacylation Kinetics Assays 
Under single-turnover conditions, enzyme concentration is much greater than substrate 
concentration, so it can be assumed that all of the substrate will be bound to enzyme at the start of 
the reaction. These conditions were chosen over traditional multiple-turnover experiments, where 
substrate concentration exceeds enzyme concentration, in part, because of the relatively rapid 
buffer hydrolysis of Ala-tRNAPro. The kobs determined by single-turnover kinetics incorporates 
both the binding and catalysis enzymatic steps and allows direct comparison of WT and ∆CTD 
ProXp-ala while minimizing the amount of radioactive tRNA necessary for the reaction. 
Each assay was performed as a time-course experiment under single-turnover conditions 
containing 750 nM of either WT or ∆CTD At ProXp-ala and 100 nM 3'-[32P]-labeled At Ala-
tRNAPro in deacylation assay buffer (50 mM HEPES pH 7.0, 20 mM KCl, 5 mM MgCl2, 2 mM 
DTT, 0.1 mg/mL BSA). To measure deacylation activity, a 1 µL aliquot was withdrawn from the 
reaction mixture at the desired timepoints and quenched with the previously described S1 nuclease 
quenching solution to cleave the radiolabeled 3' adenosine, resulting in a mix of radiolabeled AMP 
that is covalently bound to Ala or unbound depending on whether it was successfully deacylated. 
Charged Ala-[32P]-AMP was separated from deacylated [32P]-AMP via spotting on TLC plates as 
described previously. Photosensitive cassettes and ImageQuant densitometry software were used 
to measure the pixel density of each radioactive spot on the TLC plate image.  
The extent of deacylation was determined by plotting the fraction of Ala-tRNAPro 
remaining as a function of time. The kobs for each reaction was determined by fitting the 
deacylation data to an exponential decay function in the form of Y= Y0 + Ae-bx, where Y = amount 
of remaining Ala-tRNAPro, Y0 = amount of remaining Ala-tRNAPro after complete deacylation, A 
= initial amount of Ala-tRNAPro,  b = first order rate constant (kobs), and x = time.  
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Deacylation assays were performed to confirm activity of the WT and ∆CTD enzymes and 
identify any potential differences between the two proteins as a result of truncation. Additional 
deacylation assays under identical conditions, but with a range of enzyme concentrations (0.5-16 
µM) were performed by Jun-Kyu Byun (WT) and John Vu (∆CTD) to probe whether the observed 
decrease in deacylation activity of the ∆CTD was caused by a catalytic or binding defect. 
Preliminary assays under identical conditions comparing the deacylation of Hs Ala-tRNAPro by 
Hs, WT At, and ∆CTD At ProXp-ala were also performed to probe relative levels of activity 
between eukaryotic ProXp-ala. 
 
Microscale Thermophoresis Binding Assays 
For microscale thermophoresis (MST) binding studies, the surface amines of Lys residues 
on WT and ∆CTD At ProXp-ala were fluorescently labeled using the Monolith Protein Labeling 
Kit RED-NHS 2nd Generation protocol (NanoTemper). The succinimidyl ester fluorophore was 
reconstituted in 25 µL DMSO to yield a 600 µM dye stock. Each protein was diluted to 10 µM in 
90 µL NanoTemper Labeling Buffer NHS. A sample of 7 µL of dye solution was diluted 2X in 7 
µL of Labeling Buffer NHS, then 10 µL of this 300 µM dye solution was added to the 90 µL of 
10 µM protein for a total reaction volume of 100 µL and a dye to protein reaction stoichiometry 
of just over 3:1. The reaction was incubated at 25°C in the dark for 30 min, before being loaded 
onto a NanoTemper Labeling B-Column equilibrated with 10 mL of MST buffer (50 mM Tris-
HCl pH 7.8, 150 mM NaCl, 10 mM MgCl2, 0.05% (v/v) Tween-20). MST buffer (550 µL) was 
added to the column to allow the proteins to enter the resin, then 450 µL more were added to elute 
the labeled protein, which was collected. 
 45 
To determine the concentration and degree of labeling of each protein, UV-Vis absorbances 
were taken at 205, 280, and 650 nm. Since At ProXp-ala lacks Trp residues, protein concentration 
was determined using absorbance of the amide backbone at 205 nm (A205) with correction for the 
absorbance of the fluorophore at this wavelength. This corrected absorbance was divided by the 
MW of the protein in Daltons and multiplied by 31 Da-1 cm-1 according to the NanoTemper 
labeling protocol. The concentration of label was determined by dividing A650 by e650 for the 
fluorophore (195,000 M-1 cm-1). To determine the degree of labeling, the concentration of label 
was divided by the protein concentration. 
For the MST binding assays, a 12-step (WT) or 16 step (∆CTD) 2X serial dilution of 
uncharged, unlabeled At tRNAPro was performed ranging from 0-200 µM. Binding equilibrium 
samples were prepared using 10 µL of the appropriate tRNA dilution combined with 10 µL of 10 
nM WT or ∆CTD At ProXp-ala for a final protein concentration of 5 nM. The mixtures were 
allowed to equilibrate at 25°C for approximately 30 min, then they were drawn into Monolith 
NT.115 Premium Capillaries and measured and analyzed by a Monolith Pico MST instrument.  
 
Results and Discussion 
Deacylation Assays 
Deacylation assays indicate that CTD truncation results in a 19-fold average decrease in 
kobs, the apparent first-order rate constant of deacylation activity (Fig. 15A). Under single-
turnover conditions, the kobs reflects both the binding and catalysis steps. To determine whether 
the decreased deacylation activity was primarily due to a binding or catalytic defect, deacylation 
assays were performed with increasing concentrations of ProXp-ala (Fig. 15B-C). If the CTD 
was critical for catalysis, the truncation would limit the enzyme’s ability to deacylate Ala-
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tRNAPro independent of how effectively it can bind, which would be a function of enzyme 
concentration. Therefore, increasing the concentration of a “catalytically defective” ∆CTD 
ProXp-ala would result in more bound substrate, but the rate of deacylation will be limited by 
catalysis and the reaction rate would not increase. In contrast, if the enzyme acquired a binding 
defect from the truncation, providing a higher concentration of the ∆CTD ProXp-ala would 
increase the amount of bound substrate and would result in an increase in deacylation activity. 
When the concentration of the ∆CTD enzyme was increased, the deacylation rate increased 
steadily, suggesting that binding is the rate limiting step for this enzyme (Fig. 15C). This 
observation was not seen in the WT, which exhibited no change in deacylation rate with 
concentration (Fig. 15B). These observations led us to hypothesize that the CTD of plant ProXp-
ala greatly improves the binding of the protein to tRNA rather than improving catalysis. 
 
 Interspecies tRNA Deacylation 
Eukaryotic tRNAPro sequences are very similar to one another (Fig. 16A), so we 
hypothesized that At ProXp-ala would be able to successfully deacylate mischarged Hs Ala-
tRNAPro.  Deacylation assays of WT At, ∆CTD At, and Hs ProXp-ala using mischarged Hs Ala-
tRNAPro were performed under single turnover conditions and their rates of deacylation were 
compared (Fig. 16B). As hypothesized, both plant enzymes were able to successfully deacylate 
Hs Ala-tRNAPro, and the difference between their kobs was about 22-fold, very similar to the 19-
fold difference seen with At Ala-tRNAPro (Fig. 16B). The human enzyme, which lacks a CTD, 
exhibited the poorest deacylation activity of the three enzymes tested, deacylating its human 













































Figure 15. Single-turnover kinetic assays of (A) 750 nM WT and ∆CTD At ProXp-ala deacylation of At 
Ala-tRNAPro performed in duplicate with standard deviations indicated. Single trials of deacylation 
assays at varying enzyme concentrations for (B) WT (performed by Jun-Kyu Byun) and (C) ∆CTD At 
ProXp-ala. Observed rate constants, kobs, were determined by fitting the kinetic data to a first-order 










































Figure 16. (A) Sequence and secondary structure of Hs and At tRNAPro(UGG). Positions that are not 
conserved between the two species are circled. (B) Single-turnover kinetic assays of WT and ∆CTD 
At ProXp-ala and Hs ProXp-ala deacylation of Hs Ala-tRNAPro performed in duplicate with the 
standard deviation indicated. (C) kobs values and first-order exponential decay curves for each dataset 
were determined as described in Fig 15. 
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∆CTD At ProXp-ala was designed to mimic the size, structure, and function of shorter 
eukaryotic ProXp-ala, such as the protein found in humans. The similarity in their deacylation 
activity suggests that the ∆CTD variant may to some degree model the ancestral plant ProXp-ala 
from around the time that plants diverged from other eukaryotes before the evolution of a CTD. It 
is also worth noting that these findings indicate that, rather than the CTD performing a 
compensatory function to recover similar levels of deacylation as other eukaryotes, its rapid 
deacylation activity has actually improved the activity of plant ProXp-ala beyond the capacity of 
the catalytic N-terminal core alone and the potentially more ancestral version seen in humans. 
 
Comparative Binding Affinities 
Preliminary MST experiments in MST buffer (50 mM Tris-HCl pH 7.8, 150 mM NaCl, 10 
mM MgCl2, 0.05% v/v Tween-20) were performed with 5 nM of the WT and ∆CTD proteins. The 
percent labeling with the Lys-specific fluorophore used for MST was inconsistent between the two 
proteins and will require further optimization (WT: 160% and ∆CTD: 7%). Binding checks of both 
proteins confirmed that a sufficient signal-to-noise ratio was present when 25 µM of tRNA was 
used. Duplicate trials wherein the tRNA concentration ranged from 0 to 200 µM indicated that the 
WT protein appeared to exhibit binding behavior, but that saturating concentrations of tRNAPro 
were never achieved, even at 200 µM tRNA; thus, a Kd could not be determined for the WT protein 
(Fig. 17A). In contrast, effective saturation of the ∆CTD construct was achieved under the same 
conditions (but with four more steps in the serial dilution) as for the WT protein, and a binding 
curve was produced from quadruplicated trials, resulting in a calculated Kd of approximately 840 







































Figure 17. MST binding curves for two separate trials of WT (top) and four combined trials of ∆CTD 
(bottom). Normalized fluorescence (‰ relative to initial fluorescence) is plotted against molar At 
tRNAPro concentration on a log scale. WT trials have not reached saturating conditions and cannot 
be used to determine a Kd. The preliminary Kd of ∆CTD is 840 ± 290 nM. 
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The MST results suggest that the Kd of WT At ProXp-ala exceeds that of ∆CTD ProXp-
ala, a result that is inconsistent with our previously proposed model of the CTD facilitating binding 
to tRNA. While our results are preliminary and require optimization before conclusions can be 
drawn with greater confidence, a possible explanation for this result is that a longer time to 
equilibration may be necessary for the WT protein. Incubation for the first trials was only 30 
minutes, and longer incubation times may be necessary to achieve true equilibrium binding 
measurements31. Alternatively, the labeling of the fluorophore may be disrupting the function of 
the Lys-rich CTD, preventing any crucial protein-protein and protein-tRNA interactions. To assess 
the potential effect that labeling could be having on protein function, a control deacylation assay 
will need to be performed to ensure that fluorescently labeled WT and ∆CTD At ProXp-ala show 
similar changes in deacylation activity upon labeling. If the WT exhibits a more significant drop 
in deacylation activity after surface Lys labeling, or fails to exhibit the expected oligomerization 
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Conclusions and Future Directions 
 With this work, we have confirmed the expected canonical function of At ProXp-ala as an 
efficient Ala-tRNAPro deacylase and provided insights into the structure and function of this 
protein’s enigmatic C-terminal domain. Kinetic deacylation assays demonstrate that truncation of 
the At ProXp-ala CTD results in a 19-fold decrease in deacylation rate. The rate can be improved 
by increasing the concentration of enzyme in the reaction, a result that is consistent with a model 
in which the CTD improves the binding affinity of ProXp-ala to Ala-tRNAPro. Pilot 
electrophoretic mobility shift assays performed by Jun-Kyu Byun point to a binding defect as 
well, though attempts using microscale thermophoresis as an alternative technique to quantify 
the difference in the strength of binding between the At ProXp-ala variants and At tRNAPro are 
not yet conclusive. More experiments and optimization are underway to provide conclusive 
results regarding this parameter, though it is clear that the CTD has some critical function that 
manifests as a change in deacylation rate.  
SEC-MALLS measurements performed by Dr. William Cantara from the Musier-Forsyth 
lab are consistent with the WT protein forming a higher order dimer or trimer, whereas the 
DCTD variant is exclusively monomeric. Additionally, SEC-MALLS measurements performed 
by Dr. Marina Bakhtina with the WT protein and At tRNAPro revealed that WT ProXp-ala forms 
a complex with tRNA exclusively as a dimer (data not shown). These data are consistent with 
bioinformatics analyses (Chapter 2) and suggest that oligomerization may be a pre-requisite for 
effective tRNA binding. Further studies investigating the binding stoichiometry of the ∆CTD to 
tRNA are planned, as well as experiments to probe these interactions via native mass 
spectrometry. 
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 Given the structural and functional similarities between human ProXp-ala and ∆CTD At 
ProXp-ala, it is very likely that the CTD evolved uniquely in plants from a common eukaryotic 
ProXp-ala ancestor similar to the human ProXp-ala. Once the functions of the CTD are better 
characterized, we will design a chimeric +CTD Hs ProXp-ala protein construct in which the 
CTD of At ProXp-ala is fused to the C-terminus of Hs ProXp-ala. Because of the similarity in the 
structure and function of Hs and ∆CTD At ProXp-ala, and the evidence that has been found for 
the CTD performing a facilitatory binding function, we hypothesize that this chimeric fusion 
would exhibit similarly improved (~20 fold) deacylation activity compared to the WT Hs 
enzyme without a CTD. Improved deacylation by the chimera will suggest an ancient 
evolutionary mechanism that placed selective pressure on plants to improve the rate of ProXp-ala 
deacylation activity that was not present in human evolution. This deficiency in ProXp-ala 
deacylation within humans, if confirmed in vivo, could therefore serve as a potential limitation of 
human translational fidelity machinery, and it could inform potential mechanisms of disease, 
such as neurodegeneration which has been shown to be a product of failed aa-tRNA editing4. 
 The tendency for WT At ProXp-ala to interact with itself during storage has also 
informed future plans that involve looking deeper at the types of protein-protein interactions that 
may be facilitated by the CTD in vivo. In fact, while it has been well established that humans 
possess a multi-synthetase complex (MSC), very recently, the first plant MSC was identified, 
and it was found that At ProXp-ala participates in this complex32. This finding is in contrast to Hs 
ProXp-ala which has not been reported to participate in the human MSC. Therefore, we 
hypothesize that the CTD may play a significant role in the ability of At ProXp-ala to stably 
associate with the plant MSC. Thus, comparing the in vivo binding partners of WT and ∆CTD At 
ProXp-ala is a future direction of this project.  
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This work has begun to shed a light on the structure, function, and evolution of the 
enigmatic C-terminal extension of plant ProXp-ala. Our current results are consistent with a 
model in which the ubiquitously conserved N-terminal catalytic core of the protein retains a level 
of Ala-tRNAPro deacylase activity similar to other eukaryotic systems, while a highly helical 
CTD attached to the N-terminal core by a random linker domain appears to facilitate a greater 
rate of in vitro deacylation, potentially by enhancing binding to the Ala-tRNAPro substrate or 
facilitating protein oligomerization that improves deacylation. 
Our findings have expanded our understanding of eukaryotic translational fidelity to the 
plant kingdom and, in doing so, have revealed alternative mechanisms of translational fidelity 
between eukaryotic systems. These findings have potential industrial implications for pesticides 
by exploiting differences in the efficiency of translational fidelity machinery between plants, 
parasitic organisms, and bacteria. If plants are found to have enhanced translational fidelity 
relative to other organisms in vivo, then plants may be tolerant to higher levels of proteinogenic 
and nonproteinogenic amino acids that would be toxic to other species. The results of this study 
may also inform future medical applications by identifying a potential mechanism for 
overcoming poor translational fidelity in humans, which has been implicated in 
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